Atrial fibrillation, or A-fib, is the most common cardiac arrythmia, particularly in senior adults. A-fib occurs when the upper chambers of the heart beat irregularly and often rapidly—out of sync with the lower chambers. An irregular heartbeat might be dangerous, particularly in people with other health conditions like high blood pressure or diabetes.
If your at-risk patient shows signs of atrial fibrillation, you may want to intervene before their condition worsens. Treatment is crucial to prevent serious complications such as blood clots, stroke and heart failure. Treatment options encompass a variety of medications and interventions, including drugs, cardioversion and cardiac ablation.
Get personalized education right in your inbox.
Select Your Interests
The AMA Ed Hub makes it easy for physicians, medical students, residents, nurses and other medical professionals caring for patients with atrial fibrillation to stay up to date on the vast array of treatment options. Start with this CME course from JN Learning™ to better understand how to detect, diagnose and manage the condition. You can also add "Atrial Fibrillation" as a topic of interest on the AMA Ed Hub to get the latest on advances in treatment, recent guidelines and more.
In addition to the self-paced CME course, the AMA Ed Hub provides research articles comparing different treatment approaches to a-fib. The following are accompanied by quizzes to earn CME credit:
Looking at patients with persistent atrial fibrillation, researchers found that treatment combining catheter ablation and vein of Marshall ethanol infusion showed a statistically significant reduction in recurrence—and better outcomes—in comparison to catheter ablation alone after 6 and 12 months. Keep reading to find out more about the implications for secondary outcomes such as perimetral block.
This clinical trial found that there was no statistically significant difference in patient-reported quality of life among those with atrial fibrillation and symptoms of heart failure when using digoxin versus bisoprolol (a β-blocker) for heart rate control. Learn more about the testing scales used as well as the secondary endpoints.
Until now, there was limited data behind clinical guidance recommending direct oral anticoagulants (DOACs) over warfarin—for patients with atrial fibrillation who also have ischemic stroke—and it was based exclusively on clinical trial data. Read the findings to learn more about this new real-world data, how this cohort study was set up and for more detailed study findings.
Among adults aged 65 or older with atrial fibrillation, researchers observed positive correlation between treatment with rivaroxaban (versus apixaban) and a significantly increased risk of major ischemic and hemorrhagic events. Consider these findings as you make clinical decisions.
Whether a patient requires medication, cardioversion, ablation or surgery for atrial fibrillation depends on that patient’s medical history, symptoms and preferences. Treatment should be individualized. The American Heart Association and StopAFib.org offer a downloadable worksheet, Partnering in Your Treatment, to help patients with atrial fibrillation collaborate with their health care provider on a treatment plan.
Explore the latest in dosing, safety, periprocedural management and more.
Learn how to manage transient ischemic attack (TIA) and ischemic and hemorrhagic stroke.
Familiarize yourself with recent guidelines and advances in the treatment of heart failure.
You currently have no searches saved.
You currently have no courses saved.